More importantly, TAP was detected more frequently among patients with cancer than other known markers, including AFP and CA19-9, in liver and pancreatic cancer, suggesting the promise of TAP as universal cancer marker. This evidence concerns the gene AFP and familial pancreatic carcinoma.